Deborah Fowell
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
T-Lymphocytes, Regulatory | 8 | 1991 | 32 |
Why?
| CD4-Positive T-Lymphocytes | 16 | 1991 | 113 |
Why?
| Th2 Cells | 11 | 1996 | 36 |
Why?
| Leishmania major | 14 | 1995 | 7 |
Why?
| Leishmaniasis, Cutaneous | 15 | 1995 | 4 |
Why?
| Interleukin-2 Receptor alpha Subunit | 4 | 2006 | 9 |
Why?
| Immune Tolerance | 8 | 1991 | 72 |
Why?
| Protein-Tyrosine Kinases | 4 | 1999 | 77 |
Why?
| Cytokines | 11 | 1992 | 207 |
Why?
| T-Lymphocyte Subsets | 11 | 1991 | 70 |
Why?
| Interleukin-4 | 10 | 1993 | 62 |
Why?
| Chemokines | 2 | 2004 | 48 |
Why?
| Autoimmunity | 6 | 1991 | 27 |
Why?
| Mice | 30 | 1995 | 623 |
Why?
| Antigens, CD4 | 4 | 1991 | 29 |
Why?
| Interferon-gamma | 8 | 1996 | 133 |
Why?
| Diabetes Mellitus, Type 1 | 3 | 1996 | 58 |
Why?
| Animals | 40 | 1991 | 1031 |
Why?
| Interleukin-2 | 5 | 1993 | 71 |
Why?
| Wiskott-Aldrich Syndrome Protein | 2 | 2004 | 1 |
Why?
| T-Lymphocytes | 7 | 1996 | 182 |
Why?
| Mice, Inbred BALB C | 13 | 1996 | 176 |
Why?
| Lymphocyte Activation | 9 | 1991 | 137 |
Why?
| Interleukin-17 | 1 | 2011 | 11 |
Why?
| Forkhead Transcription Factors | 1 | 2011 | 44 |
Why?
| Lymphopenia | 2 | 1996 | 4 |
Why?
| Wiskott-Aldrich Syndrome | 2 | 2004 | 6 |
Why?
| Killer Cells, Natural | 3 | 1996 | 62 |
Why?
| Host-Pathogen Interactions | 1 | 2008 | 15 |
Why?
| Inflammation | 2 | 2008 | 208 |
Why?
| Mice, Knockout | 7 | 1998 | 265 |
Why?
| Diabetes Mellitus | 1 | 2008 | 72 |
Why?
| Antigens, CD | 1 | 2009 | 128 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 1996 | 210 |
Why?
| Th1 Cells | 6 | 1996 | 33 |
Why?
| Cell Proliferation | 5 | 2005 | 227 |
Why?
| Antigens, Protozoan | 4 | 1998 | 6 |
Why?
| Cells, Cultured | 8 | 1997 | 447 |
Why?
| Mice, Inbred C57BL | 12 | 1996 | 318 |
Why?
| Lymph Nodes | 4 | 2000 | 106 |
Why?
| Gene Expression Regulation | 2 | 1999 | 277 |
Why?
| Proteins | 2 | 1996 | 192 |
Why?
| Signal Transduction | 2 | 2006 | 313 |
Why?
| DNA-Binding Proteins | 2 | 1999 | 204 |
Why?
| Transcription Factors | 2 | 1999 | 201 |
Why?
| GATA3 Transcription Factor | 2 | 2007 | 5 |
Why?
| Diabetes Mellitus, Experimental | 4 | 1991 | 36 |
Why?
| Autoimmune Diseases | 4 | 1991 | 49 |
Why?
| Disease Susceptibility | 4 | 1998 | 61 |
Why?
| Interleukin-12 | 3 | 1995 | 27 |
Why?
| Cell Differentiation | 5 | 1997 | 262 |
Why?
| Genetic Predisposition to Disease | 1 | 1999 | 131 |
Why?
| Cell Communication | 2 | 2006 | 72 |
Why?
| Nuclear Proteins | 1 | 1999 | 139 |
Why?
| Transcription, Genetic | 3 | 2006 | 253 |
Why?
| Adoptive Transfer | 2 | 1996 | 16 |
Why?
| Immunity | 3 | 1996 | 46 |
Why?
| Mice, Inbred Strains | 2 | 1999 | 118 |
Why?
| Coculture Techniques | 2 | 2006 | 59 |
Why?
| Mice, Transgenic | 6 | 1996 | 209 |
Why?
| Antigens, CD28 | 2 | 1999 | 25 |
Why?
| Protozoan Proteins | 4 | 1998 | 13 |
Why?
| Nippostrongylus | 2 | 1999 | 3 |
Why?
| Antigens, CD45 | 5 | 1991 | 30 |
Why?
| Strongylida Infections | 2 | 1996 | 3 |
Why?
| Thymus Gland | 3 | 1996 | 57 |
Why?
| Colitis | 2 | 1997 | 14 |
Why?
| Mice, Inbred NOD | 2 | 1999 | 24 |
Why?
| Humans | 11 | 1992 | 1856 |
Why?
| Antigens, Surface | 2 | 1996 | 51 |
Why?
| Female | 11 | 1993 | 1643 |
Why?
| Hypersensitivity | 1 | 2010 | 39 |
Why?
| Longitudinal Studies | 1 | 2011 | 195 |
Why?
| Disease Models, Animal | 2 | 1998 | 349 |
Why?
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2009 | 2 |
Why?
| CTLA-4 Antigen | 1 | 2009 | 10 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 1993 | 18 |
Why?
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 12 |
Why?
| Ligands | 2 | 1999 | 116 |
Why?
| Epitopes | 4 | 1991 | 86 |
Why?
| Tryptophan | 1 | 2009 | 21 |
Why?
| Communicable Diseases | 2 | 1998 | 22 |
Why?
| Protein Inhibitors of Activated STAT | 1 | 2007 | 5 |
Why?
| Immune System | 1 | 2009 | 43 |
Why?
| Receptors, Antigen, T-Cell | 2 | 1997 | 34 |
Why?
| Up-Regulation | 1 | 2009 | 183 |
Why?
| Spleen | 1 | 2009 | 129 |
Why?
| Binding, Competitive | 1 | 2008 | 109 |
Why?
| Growth Substances | 1 | 2008 | 51 |
Why?
| Peptide Fragments | 2 | 1999 | 144 |
Why?
| Adenosine Monophosphate | 1 | 2006 | 14 |
Why?
| 5'-Nucleotidase | 1 | 2006 | 7 |
Why?
| Clonal Anergy | 1 | 2006 | 20 |
Why?
| Interleukin-10 | 3 | 1993 | 38 |
Why?
| Growth Inhibitors | 1 | 2006 | 33 |
Why?
| Enzyme Inhibitors | 1 | 2009 | 216 |
Why?
| Histocompatibility Antigens Class II | 2 | 1997 | 50 |
Why?
| Adenosine | 1 | 2006 | 57 |
Why?
| Inflammation Mediators | 1 | 2006 | 56 |
Why?
| Receptors, Interleukin-2 | 1 | 2005 | 31 |
Why?
| Down-Regulation | 1 | 2006 | 150 |
Why?
| Molecular Sequence Data | 6 | 1994 | 404 |
Why?
| RNA, Messenger | 3 | 1991 | 394 |
Why?
| Staining and Labeling | 1 | 2004 | 101 |
Why?
| Gene Expression Profiling | 1 | 2006 | 138 |
Why?
| Models, Biological | 1 | 2009 | 410 |
Why?
| Amino Acid Sequence | 4 | 1998 | 319 |
Why?
| Kinetics | 1 | 2006 | 349 |
Why?
| Recombinant Fusion Proteins | 3 | 1994 | 189 |
Why?
| Child | 1 | 2011 | 749 |
Why?
| Adolescent | 1 | 2011 | 891 |
Why?
| Thymectomy | 3 | 1993 | 11 |
Why?
| Rats | 8 | 1991 | 530 |
Why?
| Vaccines, DNA | 1 | 2000 | 16 |
Why?
| Antigens, CD27 | 1 | 1999 | 7 |
Why?
| Cell Division | 2 | 1999 | 273 |
Why?
| Ionomycin | 1 | 1999 | 12 |
Why?
| Ionophores | 1 | 1999 | 15 |
Why?
| NFATC Transcription Factors | 1 | 1999 | 15 |
Why?
| Specific Pathogen-Free Organisms | 1 | 1999 | 26 |
Why?
| Insulin | 2 | 1996 | 129 |
Why?
| Biological Transport | 1 | 1999 | 129 |
Why?
| Antigens, CD8 | 2 | 1993 | 25 |
Why?
| Time Factors | 1 | 2005 | 896 |
Why?
| Male | 4 | 1993 | 1553 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2000 | 91 |
Why?
| B-Lymphocytes | 2 | 1996 | 134 |
Why?
| Cytotoxicity, Immunologic | 1 | 1998 | 54 |
Why?
| Disease Progression | 1 | 1999 | 244 |
Why?
| Transgenes | 1 | 1997 | 56 |
Why?
| Middle Aged | 1 | 2011 | 1161 |
Why?
| Prediabetic State | 1 | 1996 | 6 |
Why?
| Calcium Signaling | 1 | 1999 | 52 |
Why?
| beta 2-Microglobulin | 1 | 1996 | 17 |
Why?
| ADP Ribose Transferases | 1 | 1996 | 9 |
Why?
| Antigen-Presenting Cells | 1 | 1997 | 40 |
Why?
| Adult | 1 | 2011 | 1317 |
Why?
| Antigens | 1 | 1996 | 66 |
Why?
| Antibodies, Monoclonal | 3 | 1994 | 241 |
Why?
| Immunity, Cellular | 3 | 1999 | 85 |
Why?
| Dexamethasone | 1 | 1996 | 109 |
Why?
| Macrophages | 2 | 1993 | 148 |
Why?
| Glucocorticoids | 1 | 1996 | 107 |
Why?
| Protein Binding | 1 | 1997 | 256 |
Why?
| Protein Processing, Post-Translational | 1 | 1994 | 78 |
Why?
| Interleukin-13 | 2 | 1996 | 10 |
Why?
| Lymphocyte Depletion | 1 | 1993 | 29 |
Why?
| Mutation | 1 | 1997 | 340 |
Why?
| Bronchial Hyperreactivity | 1 | 2010 | 12 |
Why?
| Flow Cytometry | 1 | 1993 | 216 |
Why?
| Phenotype | 1 | 1993 | 303 |
Why?
| Immunohistochemistry | 1 | 1993 | 355 |
Why?
| Interleukin-5 | 1 | 2007 | 20 |
Why?
| Two-Hybrid System Techniques | 1 | 2007 | 42 |
Why?
| Retroviridae | 1 | 2007 | 36 |
Why?
| Hybridomas | 1 | 2006 | 31 |
Why?
| RNA, Small Interfering | 1 | 2007 | 116 |
Why?
| Algorithms | 1 | 2010 | 226 |
Why?
| Self Tolerance | 2 | 1996 | 4 |
Why?
| Promoter Regions, Genetic | 1 | 2007 | 188 |
Why?
| Stem Cells | 1 | 2006 | 107 |
Why?
| DNA, Protozoan | 1 | 2000 | 5 |
Why?
| Receptors, Interleukin-12 | 1 | 2000 | 5 |
Why?
| Genes, T-Cell Receptor beta | 1 | 2000 | 6 |
Why?
| Receptors, Interleukin | 1 | 2000 | 10 |
Why?
| Immune Sera | 1 | 2000 | 56 |
Why?
| Injections, Subcutaneous | 1 | 2000 | 63 |
Why?
| Base Sequence | 2 | 1994 | 371 |
Why?
| Antibodies, Helminth | 1 | 1999 | 1 |
Why?
| Receptors, OX40 | 1 | 1999 | 1 |
Why?
| Antibodies, Protozoan | 1 | 1999 | 4 |
Why?
| CD4 Lymphocyte Count | 1 | 2000 | 50 |
Why?
| Mice, Inbred CBA | 1 | 1999 | 41 |
Why?
| Mice, Mutant Strains | 1 | 1999 | 77 |
Why?
| Gene Targeting | 1 | 1999 | 51 |
Why?
| Superantigens | 1 | 1999 | 5 |
Why?
| Listeria monocytogenes | 1 | 1998 | 6 |
Why?
| Sequence Alignment | 1 | 1999 | 114 |
Why?
| Sequence Homology, Amino Acid | 1 | 1999 | 156 |
Why?
| Rats, Inbred Strains | 1 | 1999 | 170 |
Why?
| Protein Kinase C | 1 | 2000 | 93 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 1999 | 67 |
Why?
| Amino Acid Substitution | 1 | 1999 | 68 |
Why?
| Mice, Inbred DBA | 1 | 1998 | 38 |
Why?
| Clone Cells | 1 | 1998 | 92 |
Why?
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 1996 | 10 |
Why?
| Cesium Radioisotopes | 1 | 1996 | 18 |
Why?
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 1996 | 1 |
Why?
| Rats, Mutant Strains | 1 | 1996 | 14 |
Why?
| Lung Diseases, Parasitic | 1 | 1996 | 4 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1996 | 23 |
Why?
| Antigens, Ly | 1 | 1996 | 7 |
Why?
| Hemocyanin | 1 | 1996 | 16 |
Why?
| Schistosomiasis mansoni | 1 | 1996 | 4 |
Why?
| Lectins, C-Type | 1 | 1996 | 19 |
Why?
| Mice, Inbred C3H | 1 | 1997 | 86 |
Why?
| Mucous Membrane | 1 | 1996 | 37 |
Why?
| Granuloma | 1 | 1996 | 38 |
Why?
| Clonal Deletion | 1 | 1996 | 6 |
Why?
| Whole-Body Irradiation | 1 | 1996 | 43 |
Why?
| Concanavalin A | 1 | 1996 | 25 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 1 | 1996 | 9 |
Why?
| Evaluation Studies as Topic | 1 | 1996 | 178 |
Why?
| Autoantigens | 1 | 1996 | 29 |
Why?
| Lymphatic System | 1 | 1996 | 12 |
Why?
| Lymphocytes | 1 | 1997 | 142 |
Why?
| Glycosylation | 1 | 1994 | 37 |
Why?
| Immunoglobulin Fab Fragments | 1 | 1994 | 23 |
Why?
| Recombinant Proteins | 1 | 1998 | 290 |
Why?
| DNA Primers | 1 | 1996 | 208 |
Why?
| Alternative Splicing | 1 | 1994 | 51 |
Why?
| Glutathione Transferase | 1 | 1994 | 45 |
Why?
| Lung Neoplasms | 1 | 1997 | 159 |
Why?
| Membrane Glycoproteins | 1 | 1996 | 154 |
Why?
| Histocompatibility Antigens | 1 | 1991 | 17 |
Why?
| Antigens, Differentiation | 1 | 1991 | 53 |
Why?
| Lymphokines | 1 | 1991 | 61 |
Why?
|
|
Fowell's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|